Preview: the ratios on this page are sample data, not real screening results.

Screener / Health Care / Johnson & Johnson

JNJ · NYSE

Johnson & Johnson

Under AAOIFI Standard 21, Johnson & Johnson is compliant. It passes all three tests.

Market cap$380bn
SectorHealth Care
CountryUnited States
Reviewed30 Sept 2026
CompliantJohnson & JohnsonJNJ · NYSE
2.9%Impure revenue
limit 5%
8.9%Debt / market cap
limit 30%
5.8%Interest deposits
limit 30%

Result by standard.

Each screening body sets its own limits and measures debt against a different base.

StandardDebt measured againstDebt limitResult
AAOIFI No. 21Market cap30%Compliant
S&P Shariah36-month average market cap33%Compliant
MSCI IslamicTotal assets33.33%Compliant
Dow Jones Islamic24-month average market cap33%Compliant

Debt over eight quarters.

Interest-bearing debt as a share of market cap, now 8.9% (down 0.4 points on the previous quarter). The shaded band is the doubtful zone.

0%10%20%30%LIMIT 30%Q4 2024: 9.3%Q1 2025: 8.9%Q2 2025: 8.4%Q3 2025: 9.3%Q4 2025: 8.9%Q1 2026: 8.4%Q2 2026: 9.3%Q3 2026: 8.9%Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26

Purify in one step.

If a compliant company still earns a little impure income, the same share of your dividend goes to charity. Move the slider to see yours.

$1,000 dividends × 2.9% impure revenue = $29.00
$29.00

to donate from Johnson & Johnson dividends

Sources: latest annual report and interim financial statements filed with NYSE. Purindex publishes this screening to help people understand what they own. It does not recommend buying, selling or holding Johnson & Johnson or any other security.